US2023297853A1PendingUtilityA1
System and method for the latent space optimization of generative machine learning models
Est. expiryDec 16, 2040(~14.4 yrs left)· nominal 20-yr term from priority
G06N 3/0464G06N 3/091G06N 3/094G06N 3/0442G06N 3/0455G06N 3/092G06N 3/09G06N 3/0475G06N 3/088G06N 5/022G06N 3/084G06V 10/751G06V 10/82G16C 20/30G16C 20/50G16C 20/70G16C 20/90G16B 15/30G16B 40/20G06N 3/047G06N 3/048G06N 3/044G06N 3/045G06N 7/01G06N 3/096G06F 16/951G06N 3/08G16B 15/00G16B 40/00G16B 45/00G16B 50/10G06F 18/22
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A system and method for optimizing the latent space in generative machine learning models, and applications of the optimizations for use in the de novo generation of molecules for both ligand-based and pocket-based generation. The ligand-based optimizations comprise a tunable reward system based on a multi-property model and further define new measurable metrics: molecular novelty and uniqueness. The pocket-based optimizations comprise an initial multi-property optimization followed up by either a seed-based optimization or a relaxed-based optimization.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A system for optimizing the latent space in generative machine learning models, comprising:
a computer system comprising a memory and a processor; a latent space optimization module, comprising a plurality of programming instructions stored in the memory and operating on the processor, wherein the plurality of programming instructions, when operating on the processor, causes the computer system to:
train a machine learning model to represent a plurality of properties of a common object;
receive a seed object of the same type of object as the common object;
optimize the seed object's properties using the machine learning model, wherein the plurality of optimized seed object properties forms a mixed objective; and
maximize the mixed objective by performing gradient descent on a latent space vector encoded from the seed object.
2 . The system of claim 1 , wherein one model in the plurality of machine learning models is a 3D model trained on ground truths extracted from cheminformatics software to predict synthetic accessibility.
3 . The system of claim 1 , wherein one model in the plurality of machine learning models is a 3D model trained on ground truths extracted from cheminformatics software to predict drug-likeness.
4 . The system of claim 1 , wherein one model in the plurality of machine learning models is a model trained on poses of ligands docked in protein binding pockets and finetuned on public protein databases to provide bioactivity affinity based on IC50 values.
5 . The system of claim 1 , wherein one model in the plurality of machine learning models is a model trained on poses of ligands docked in protein binding pockets to determine whether a conformer's pose relative to a binding site is the correct docked pose.
6 . The system of claim 1 , wherein one model in the plurality of machine learning models is a discriminator model which discriminates between generated and real molecules.
7 . A method for optimizing the latent space in generative machine learning models, comprising the steps of:
training a machine learning model to represent a plurality of properties of a common object; receiving a seed object, wherein the seed object is the same type of object as the common object; optimizing the seed object's properties using the machine learning model, wherein the plurality of optimized seed object properties forms a mixed objective; and maximizing the mixed objective by performing gradient descent on a latent space vector encoded from the seed object.
8 . The method of claim 7 , wherein one model in the plurality of machine learning models is a 3D model trained on ground truths extracted from cheminformatics software to predict synthetic accessibility.
9 . The method of claim 7 , wherein one model in the plurality of machine learning models is a 3D model trained on ground truths extracted from cheminformatics software to predict drug-likeness.
10 . The method of claim 7 , wherein one model in the plurality of machine learning models is a model trained on poses of ligands docked in protein binding pockets and finetuned on public protein databases to provide bioactivity affinity based on IC50 values.
11 . The method of claim 7 , wherein one model in the plurality of machine learning models is a model trained on poses of ligands docked in protein binding pockets to determine whether a conformer's pose relative to a binding site is the correct docked pose.
12 . The method of claim 7 , wherein one model in the plurality of machine learning models is a discriminator model which discriminates between generated and real molecules.Join the waitlist — get patent alerts
Track US2023297853A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.